Objective: The increase in coronary blood flow (CBF) in response to endothelium-dependent vasodilators is reduced in congestive heart failure (CHF) suggesting endothelial dysfunction. However, increases in extravascular compressive forces secondary to elevated left ventricular diastolic pressure (LVEDP) in CHF might contribute to this abnormality. Methods: We measured CBF responses to intracoronary doses of the endothelium-dependent vasodilators acetylcholine (ACH) and bradykinin (BK) and the endotheliumindependent vasodilator sodium nitroprusside (SNP) in the same eight dogs before (control) and after CHF was produced by 2363 days of rapid ventricular pacing. In five of the dogs with CHF the zero-flow pressure (P ), which reflects extravascular compressive forces in zf the maximally vasodilated coronary circulation (adenosine) was measured and found to strongly correlate with LVEDP (r50.91). Coronary vascular resistance (CVR) at each concentration of vasodilator before and after the development of CHF was corrected for estimated coronary back pressure: CVR5(P 2LVEDP) / CBF, where P is mean aortic pressure. Results: CHF resulted in a significant Ao Ao decrease in CBF and increase in heart rate and LVEDP compared to control (P,0.05). The CBF responses to ACH, BK and SNP were all significantly reduced in the failing hearts (P,0.01). However, after correction for the elevated LVEDP in CHF, the response of CVR to the endothelium-dependent vasodilators was not different from normal. Conclusion: These findings suggest that endothelium mediated vasodilation is preserved in CHF, but that increased extravascular compressive forces act to limit the increase in CBF.
Introduction
ascribed to a variety of alterations that occur in CHF including heightened sympathetic tone [5] , increased proPrevious studies in patients and animals with congestive duction of vasoconstrictors such as endothelin-1 [6] and heart failure (CHF) have demonstrated abnormally inimpaired endothelial production of nitric oxide (NO) and creased vasomotor tone in the coronary circulation during other endogenous vasodilators [4] . In addition, CHF is basal conditions and a blunted increase in coronary blood accompanied by hemodynamic changes that might adflow in response to cardiac pacing [1, 2] , exercise [3] and versely affect myocardial perfusion and which could blunt infusion of vasodilators [4] . This abnormality has been the increase in coronary blood flow in response to vasodilator stimuli. Thus, the decrease in aortic pressure and increase in left-ventricular diastolic pressure (LVEDP) with progressive heart failure causes a decrease in the net q Presented in part at the 72nd Scientific Sessions of the American perfusion pressure across the coronary circulation. The
Heart Association November 1999, Atlanta, Georgia.
increase in left ventricular filling pressure may be especial-strongly correlated with the effective intramyocardial was placed in a subcutaneous pocket in the lateral chest compressive forces that act to impede coronary blood flow wall and connected to the pacing lead. Postoperative pain [7, 8] .
relief was achieved using buprenorphine (6.6 mg / kg / i.m. To account for the effects of extravascular forces, we q. 4 h) for the first 24 h postoperatively and then p.r.n. as determined zero-flow pressure (P ) in the maximally needed for relief of discomfort. Catheters were flushed zf vasodilated failing heart as an index of the effective back daily to maintain patency. pressure opposing coronary perfusion [8] . This variable was found to be strongly correlated with LVEDP. When calculations of coronary vascular resistance (CVR) in 2.2. Coronary blood flow responses in the normal heart response to the intracoronary vasodilators were corrected by subtracting LVEDP from aortic pressure, we observed One week after surgery the animals were returned to the that although the coronary flow responses to the vasodilatlaboratory and placed in a sling for control measurements ors were reduced in CHF, vascular reactivity as assessed of coronary flow responses to the endothelium-dependent by the reductions in CVR were similar in normal and agonists acetylcholine chloride (ACH, Sigma, St. Louis, failing hearts. These findings demonstrate that the endo-MO, USA) and bradykinin acetate (BK, Sigma) and the thelium remains responsive to endothelium-dependent endothelium-independent agonist sodium nitroprusside vasodilators in CHF, but that increased extravascular (SNP). Aortic and left ventricular pressures were measured compressive forces act to limit the increase in coronary with fluid-filled pressure transducers (Spectramed model blood flow.
TNF-R) at midchest level. The LV solid state micromanometer was calibrated to the fluid-filled LV catheter and pressure was recorded at normal and high gain for 2. Methods measurement of LVEDP. Data were recorded on an eightchannel direct writing recorder. After a 30-min period of Studies were carried out in eight adult mongrel dogs acclimatization to the sling, baseline hemodynamics and weighing 25-30 kg. All studies were performed in accordcoronary blood flow were recorded. ACH dissolved in ance with the Position of the American Heart Association normal saline was infused through the LAD coronary on Research Animal Use and were approved by the catheter at rates of 1.5, 3.75, 7.5, 15, 37.5 and 75 mg / min Animal Care Committee of the University of Minnesota.
(infusion rates between 0.6 and 3.0 ml / min). Coronary blood flow was recorded continuously and individual 2.1. Surgical preparation measurements at each dose of ACH were taken after blood flow had achieved a steady state (generally within 10-15 s Animals were premedicated with acepromazine (10 mg, of beginning the infusion). Infusion rates were increased at i.m.), anesthetized with sodium pentobarbital (30-35 mg / approximately 1-min intervals. Normal saline was infused kg, i.v.), intubated and ventilated with room air supat the same rate to determine the effects of vehicle on plemented with oxygen. A left thoracotomy was performed coronary blood flow. Fifteen minutes later BK dissolved in in the fifth intercostal space. A heparin-filled polyvinyl normal saline was infused through the coronary catheter in catheter, 3.0 mm O.D. was introduced into the internal a similar manner at rates of 0.3, 0.6, 1.5, 3.0 and 6.0 thoracic artery and advanced until the tip was positioned in mg / min. Following completion of the BK infusions, the the ascending aorta. The pericardium was opened and the endothelium-independent agonist SNP was infused at rates heart suspended in a pericardial cradle. A left ventricular of 7.5, 15, 37.5 and 75 mg / min. catheter and high-fidelity Konigsberg micromanometer were introduced through the apical dimple and secured in place. The proximal left-anterior descending coronary 2.3. Coronary blood flow responses in the failing heart artery (LAD) was dissected free and a hydraulic occluder and Doppler velocity probe (Craig Hartley, Houston, TX,
The day after completion of the baseline studies the USA) were placed around the vessel. A heparin-filled programmable pacemaker was activated at 220 beats / min silicone rubber catheter (0.3 mm I.D.) was placed into the and was continued at that rate or increased to 250 beats / artery immediately distal to the Doppler probe [9] . In three min if evidence of CHF did not occur after 3 weeks of of the animals a hydraulic occluder was not implanted pacing. Hemodynamics were assessed weekly during sinus because of insufficient length of the LAD artery. A rhythm with the dogs standing quietly in a sling 1 h after unipolar epicardial pacing electrode was screwed into the the pacemaker had been deactivated. CHF was deemed to right ventricle. The pericardium was loosely closed and the have developed when the resting LVEDP was greater than catheters and electrical leads were tunneled subcutaneously 20 mmHg or when the visual estimation of ejection to exit at the base of the neck. The thoracotomy was closed fraction by echocardiography was ,25%. The duration of in layers and evacuated of air. A programmable pacing pacing ranged from 14 to 39 (mean52363) days. generator (Medtronic no. 5385, Minneapolis, MN, USA)
On the day of study the pacemaker was deactivated and the dogs were placed in a sling. The catheters and flow restore normal arterial inflow. Individual measurements probe were reconnected and resting measurements of were made every 30 s. hemodynamics and blood flow were obtained 1 h after pacemaker deactivation. The coronary flow responses to ACH, BK and SNP were then repeated as previously 2.5. Data analysis described.
Heart rate, pressures and coronary velocity were measured directly from strip chart recordings. Coronary blood 2.4. Measurement of zero-flow pressure (P ) flow was calculated from the Doppler frequency shift zf 2 (kHz) using the equation q 5 2.5 3 d 3 f, where q is On a separate day measurement of zero-flow pressure to coronary blood flow in ml / min, d is the internal diameter estimate the effective back pressure to coronary perfusion of the LAD in mm and f is the Doppler frequency shift as a surrogate of extravascular compressive forces was measured in kHz [10] . Based on our previous observations performed in the five dogs with CHF in which an arterial the internal diameter of the artery was taken as 80% of the occluder had been implanted. The animals were placed in a flow probe diameter. Coronary vascular resistance (CVR) sling and aortic, LV and coronary pressures were measured in the LAD artery distribution was calculated in normal as described above. Adenosine (50 mg / kg / min) dissolved hearts and after development of CHF at baseline and in warm saline was infused into the coronary catheter at a during each infusion, subtracting LVEDP (as a surrogate rate of 0.3 ml / min throughout the study. This dose was for P ) from aortic pressure to correct for the effective zf sufficient to produce maximal vasodilation as evidenced by back pressure to coronary perfusion. Thus, CVR5(P 2
Ao the absence of reactive hyperemia following a 15-s cor-LVEDP) / CBF, where P is the mean arterial pressure.
Ao onary occlusion. While the adenosine infusion continued, The concentration of agonists to which the vessels were the LAD hydraulic occluder was inflated with saline using exposed depended not only upon the rate of infusion, but a micrometer-driven syringe to create a complete coronary also the coronary flow-rate into which the agonist was occlusion. Absence of coronary flow was confirmed by the diluted. Consequently, the agonist infused (mg / min) was flowmeter signal. The zero flow pressure was recorded by normalized to the coronary flow-rate in each animal before briefly switching the stopcock on the infusion line to the and after the development of CHF and expressed as an pressure transducer. Interruption of the adenosine infusion absolute blood concentration (Figs. 1-3 ). never exceeded 15 s. In three of the dogs the occluder was Data were compared within and between Control and partially inflated to produce 10-15 separate measurements CHF groups by ANOVA for repeated measures; a value of over a range of coronary pressure and flow to construct a P,0.05 was considered significant. When a significant full pressure-flow plot. At each measurement the occluder result was found, individual comparisons were performed was inflated for approximately 10 s to permit equilibration with the Wilcoxon signed-rank test. Data are expressed as of pressure and flow and then completely deflated to mean6S.E.M. 
3.
Results gressively increased CBF from 5868 ml / min at baseline to 130611 ml / min at the highest dose (75 mg / min) 3.1. Hemodynamics and coronary blood flow (P,0.01), with no significant change in systemic hemodynamics (Table 1 and Fig. 1 ). After the development of The development of CHF following rapid ventricular CHF, the same dose of ACH increased CBF only to 7468 pacing was associated with a decrease of mean aortic ml / min (P,0.05 vs. Control). In a similar manner, BK pressure from 11563 to 8864 mmHg; an increase of progressively increased CBF from 6065 ml / min at resting heart rate from 11965 to 141611 beats / min and baseline during control conditions to 12969 ml / min at the an increase of LVEDP from 861 to 2562 mmHg (all highest dose (6 mg / min) (P,0.01). Following the de-P,0.05) ( Table 1) . Resting coronary blood flow development of CHF, the same dose of BK increased CBF creased from 5865 to 3363 ml / min (P,0.05).
only to 84611 ml / min (P,0.05 vs. Control) ( Table 1 and Fig. 2 ). In the normal hearts infusion of the endothelium-3.2. Coronary blood flow responses to vasodilators independent vasodilator SNP progressively increased CBF from 6165 to 11066 ml / min at a dose of 75 mg / min During control experiments, intracoronary ACH pro-(P,0.01). The same dose of SNP also resulted in a occluder, P was measured during infusion of adenosine smaller increase in CBF to a maximum of 6465 ml / min in zf (50 mg / kg / min, i.c.) after the development of CHF. the failing hearts (P,0.05 vs. Control) ( Table 1 and Fig. Before beginning the adenosine infusion mean aortic 3).
pressure was 9364 mmHg, LVEDP was 2864 mmHg, heart rate was 138612 mmHg and CBF was 3363 ml/min 3.3. Coronary vascular resistance in response to ( Table 2) . During intracoronary infusion of adenosine CBF vasodilators increased to 96612 ml / min (P,0.05) but there was no significant change in the other hemodynamic variables. Because of the increase in LVEDP in the failing hearts Fig. 4 shows the coronary pressure-flow relationship and its direct correlation with P , coronary vascular zf observed in one animal during control conditions and after resistance curves were constructed for each vasodilator the development of CHF. In this animal P increased from incorporating LVEDP into the calculation to approximate zf 12 mmHg during control conditions to 27 mmHg after the effective back pressure to coronary perfusion. In the development of CHF, while LVEDP increased from 13 to same dogs baseline CVR was 1.9960.29 mmHg / ml / min during control conditions and was 2.0460.28 mmHg / ml / min after the development of CHF (Table 1) . During infusion of ACH, CVR was decreased in both groups to similar values at the highest dose of 75 mg / min i.c. (0.8360.09 vs. 0.7660.06 mmHg / ml / min; P,0.01 vs. baseline, Fig. 1) . Similarly, BK decreased CVR to a similar level at the highest dose (6 mg / min) to 0.8560.09 during control conditions and to 0.8760.09 mmHg / ml / min after the development of CHF (P,0.01 vs. baseline, Fig. 2 ). SNP decreased CVR in a dose-dependent manner in both normal (control) and CHF hearts. However, the fall in CVR to increasing doses of SNP was less in CHF than in normal hearts (P,0.05; Fig. 3 ). In the five dogs with a hydraulic coronary artery the response to intracoronary substance P was preserved in patients with dilated cardiomyopathy, suggesting intact endothelium-mediated vasodilation but impaired muscarinic receptor activity. Wang et al. [4] reported that the coronary flow responses to acetylcholine and nitroglycerine were reduced in dogs with pacing-induced CHF. However, the drugs were administered intravenously, producing substantial decreases of arterial pressure and increases of heart rate that might have influenced the results. In that studies [4] the oxidative products of NO (NO ) from isolated epicardial arteries and coronary x microvessels were reduced in dogs with CHF during both basal and acetylcholine-stimulated conditions. In subsequent studies [14] these investigators found that the coronary arteriovenous production of NO decreased dur- pacing, although the production of NO to endotheliumx these animals P was also determined during control conditions prior to zf dependent agonists was not measured.
the onset of pacing.
4.2.
Effect of extravascular compressive forces 31 mmHg. For the five dogs in which a coronary occluder was implanted, coronary flow ceased at a mean intracoronPrevious reports of coronary resistance in the failing ary pressure of 2664 mmHg. As shown in Fig. 5, this heart have calculated vascular resistance as the ratio of measurement of P was significantly correlated with arterial pressure (P ) to CBF (Q), thus assuming that the zf a LVEDP (P,0.01). coronary outflow pressure is negligible. This assumption neglects the contribution of the elevated LV diastolic intracavitary pressure to the extravascular compressive 4. Discussion forces that act to impede blood flow in the myocardium. Permut and Reilly [15] demonstrated that true vascular This study presents several new findings regarding the resistance should be defined as (P 2 P ) /Q, where P is a c c effects of increased extravascular compressive forces on the effective back pressure that results as extravascular agonist mediated coronary vasodilation in the failing heart, compressive forces interact with the intravascular distendincluding the first description of changes in coronary blood ing pressure in a collapsable segment of the vasculature to flow in response to intracoronary endothelium-dependent form vascular waterfalls. This phenomenon has been and independent agonists in the same animals before and demonstrated to occur in the coronary circulation during after the development of CHF. The data demonstrate that both systole and diastole [7, 8, 16] so that coronary back the increased LV diastolic pressure in the failing heart is pressure exceeds venous pressure measured in the coronary associated with an increased P that contributes to the sinus or right atrium [17] . The effective back pressure to zf decreased response to the vasodilators. coronary perfusion can be experimentally estimated in the maximally vasodilated coronary circulation as the zero-4.1. Endothelial function in the failing heart flow pressure (P ). In the normal heart, Ellis and Klocke zf [7] demonstrated that an increase in LVEDP from 6 to 16 There is controversy concerning the effect of CHF on mmHg caused an increase of the P from 12 to 19 mmHg, zf coronary endothelial function. Several investigators have while Duncker et al. [18] observed that as the LVEDP reported that the epicardial artery dilator response to increased from 20 mmHg at rest to 37.5 mmHg during acetylcholine is impaired in CHF [4, 11] , while others have exercise in dogs with left ventricular hypertrophy, the P zf found no difference in the maximum relaxation produced increased from 26 to 41 mmHg. Our measurements are the by acetylcholine between epicardial coronary arteries from first report of P in the failing heart and also demonstrate zf CHF and normal animals [12] . Unlike epicardial arteries, a good correlation between LVEDP and P (Fig. 5) . Our zf however, the response of coronary blood flow to vasodilatfindings indicate that the effective back pressure to corors is determined not only by the responsiveness of the onary perfusion is elevated in the failing heart and must be resistance vessels but also by the extravascular forces that accounted for when coronary resistance is calculated. surround the intramural coronary microvessels [7] . Several investigators have observed that the increase of coronary 4.3. Coronary responses to vasodilators blood flow produced by intra-arterial acetylcholine is reduced in patients with CHF suggesting endothelial This study reports the first measurements of the redysfunction [11] . However, Holdright et al. [13] found that sponses of coronary flow and vascular resistance to intracoronary administration of endothelium-dependent and this enzyme resulted in 80-90% inhibition of the vasodi--independent vasodilators in the same animals before and lator response. In the wild type mouse, vasodilation to after the development of CHF. Our findings that coronary ACH was mediated principally through NO, as EDHF flow responses are impaired after the development of CHF contributed to arteriolar vasodilation to a significant degree are in agreement with other studies [2] [3] [4] . However, the only after blockade of NOS with LNNA. Although blocdegree of impairment of the coronary flow response to the kade of EET synthesis has not been accomplished in the endothelium-independent vasodilator sodium nitroprusside intact animal, our results demonstrating that endotheliumwas similar to the impairment of the responses to the dependent vasodilator activity is not markedly impaired in endothelium-dependent vasodilators, suggesting that endothe coronary circulation of the failing heart might be thelial changes were not the primary cause of this abnorexplained by increased importance of these alternate mality. Furthermore, the impairment of the coronary flow vasodilator mechanisms. responses could be explained by an abnormally increased extravascular component of coronary resistance with no impairment of the response of the vascular component of 5. Conclusions resistance. Thus, the novel finding of our study is that the response of coronary vascular resistance to endotheliumCoronary flow responses to endothelium-dependent and dependent vasodilators was unchanged in the failing hearts -independent vasodilators were reduced after the developwhen the responses were corrected for the elevated LV ment of CHF. However, the reductions in coronary vascudiastolic pressure. In contrast to the endothelium-depenlar resistance evoked by these compounds were similar to dent vasodilators, the fall in CVR in the failing hearts in normal when the effective back pressure to coronary response to the endothelium-independent vasodilator SNP perfusion was taken into account. These findings demonwas shifted rightward compared to normal. This contrasts strate that the coronary circulation of the failing heart to previous findings in the peripheral circulation where the retains significant vasodilating capability in response to response to SNP was unchanged in patients with CHF [19] endothelium-dependent agonists, although coronary flow and in isolated epicardial coronary artery segments where responses are reduced as a result of increased extravascular the response to nitroglycerine was unchanged [20] . These compressive forces. findings may suggest that smooth muscle sensitivity or bioavailability of NO donors differs between conduit vessels and the microcirculation or, alternatively, that Acknowledgements alternate vasodilator pathways (such as EDHF) assume greater importance in the failing heart. This study was supported by U.S. Public Health Service Our findings are not incompatible with previous studies Grants HL20598, HL58067 and HL21872 from the Nasuggesting that CHF results in an impaired basal or tional Heart, Lung and Blood Institute. Jay H. Traverse stimulated NO release by the coronary endothelium, since was supported by a Scientist Development Grant from the the endothelium produces other vasodilator substances in American Heart Association. addition to NO in response to ACH and BK [21, 22] . For
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